Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

[490] P. A. C. t’Hoen, Y. Ariyurek, H. H. Thygesen, E. Vreugdenhil, R. H. A. M. Vossen,
R. X. De Menezes, J. M. Boer, G.-J. B. Van Ommen, and J. T. Den Dunnen. Deep
sequencing-based expression analysis shows major advances in robustness, resolution
and inter-lab portability over five microarray platforms. Nucleic Acids Research,
36(21):e141–e141, Oct. 2008.
[491] C. Thomas, G. Ely, C. D. James, R. Jenkins, M. Kastan, A. Jedlicka, P. Burger, and
R. Wharen. Glioblastoma-related gene mutations and over-expression of functional
epidermal growth factor receptors in SKMG-3 glioma cells. Acta neuropathologica,
101(6):605–615, June 2001.
[492] J. Ting and J. Trowsdale. Genetic control of mhc class ii expression. Cell, 109(2):S21–
S33, 2002.
[493] E. Tobias, A. Hurlstone, E. MacKenzie, R. McFarlane, D. Black, et al. The tes gene at
7q31. 1 is methylated in tumours and encodes a novel growth-suppressing lim domain
protein. Oncogene, 20(22):2844, 2001.
[494] V. Tropepe, M. Sibilia, B. Ciruna, J. Rossant, E. Wagner, and D. Kooy. Distinct neural
stem cells proliferate in response to egf and fgf in the developing mouse telencephalon.
Developmental biology, 208(1):166–188, 1999.
[495] L. Trotman, X. Wang, A. Alimonti, Z. Chen, J. Teruya-Feldstein, H. Yang,
N. Pavletich, B. Carver, C. Cordon-Cardo, H. Erdjument-Bromage, et al. Ubiquitination
regulates pten nuclear import and tumor suppression. Cell, 128(1):141–156,
2007.
[496] A. B. Trovó-Marqui and E. H. Tajara. Neurofibromin: a general outlook. Clinical
genetics, 70(1):1–13, July 2006.
[497] C. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu, Z. Chen, K. Yoshimoto, P. Mischel,
T. Cloughesy, L. Liau, et al. Primary glioblastomas express mesenchymal stem-like
properties. Molecular cancer research, 4(9):607–619, 2006.
[498] A. Tsuchida, T. Okajima, K. Furukawa, T. Ando, H. Ishida, A. Yoshida, Y. Nakamura,
R. Kannagi, M. Kiso, and K. Furukawa. Synthesis of disialyl lewis a (lea) structure in
colon cancer cell lines by a sialyltransferase, st6galnac vi, responsible for the synthesis
of α-series gangliosides. Journal of Biological Chemistry, 278(25):22787–22794, 2003.
[499] N. Tsuji, K. Kondoh, M. Furuya, D. Kobayashi, A. Yagihashi, Y. Inoue, T. Meguro,
S. Horita, H. Takahashi, and N. Watanabe. A novel aspartate protease gene, alp56,
is related to morphological features of colorectal adenomas. International journal of
colorectal disease, 19(1):43–48, 2004.
[500] V. Turk, B. Turk, G. Guncar, D. Turk, and J. Kos. Lysosomal cathepsins: structure,
role in antigen processing and presentation, and cancer. Advances in enzyme
regulation, 42:285, 2002.
[501] A. Tzschach, A. Bisgaard, M. Kirchhoff, L. Graul-Neumann, H. Neitzel, S. Page,
A. Ahmed, I. Müller, F. Erdogan, H. Ropers, et al. Chromosome aberrations involving
10q22: report of three overlapping interstitial deletions and a balanced translocation
disrupting c10orf11. European Journal of Human Genetics, 18(3):291–295, 2009.
[502] N. Uchida, D. Buck, D. He, M. Reitsma, M. Masek, T. Phan, A. Tsukamoto, F. Gage,
and I. Weissman. Direct isolation of human central nervous system stem cells. Proceedings
of the National Academy of Sciences, 97(26):14720, 2000.
[503] M. Van De Wiel, K. Kim, S. Vosse, W. Van Wieringen, S. Wilting, and B. Ylstra.
Cghcall: calling aberrations for array cgh tumor profiles. Bioinformatics, 23(7):892–
894, 2007.
[504] J. Van Den Boom, M. Wolter, R. Kuick, D. Misek, A. Youkilis, D. Wechsler, C. Sommer,
G. Reifenberger, and S. Hanash. Characterization of gene expression profiles
associated with glioma progression using oligonucleotide-based microarray analysis
and real-time reverse transcription-polymerase chain reaction. The American journal
of pathology, 163(3):1033–1043, 2003.
[505] A. Van der Krol, L. Mur, M. Beld, J. Mol, and A. Stuitje. Flavonoid genes in petunia:
addition of a limited number of gene copies may lead to a suppression of gene
expression. The Plant Cell Online, 2(4):291, 1990.